drugset / Trial / NCT00075647

CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT00075647

Phase 2 Completed 40 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Drugs used in chemotherapy, such as CCI-779, work in different ways to stop tumor cells from dividing so they stop growing or die. This phase II trial is studying how well CCI-779 works in treating patients with locally advanced or metastatic pancreatic cancer

Timeline

Start
2003-12
Primary completion
2005-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Temsirolimus Small molecule Intravenous